|
HNRNPH1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.75590661402703E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.69808611616418E-12 |
| Stage1-vs-Stage2 |
2.639000E-01 |
| Stage1-vs-Stage3 |
6.364100E-02 |
| Stage1-vs-Stage4 |
6.746400E-02 |
| Stage2-vs-Stage3 |
8.318200E-01 |
| Stage2-vs-Stage4 |
6.239800E-01 |
| Stage3-vs-Stage4 |
6.990200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.19699999970402E-07 |
| Normal-vs-Asian |
2.57050047913765E-10 |
| Caucasian-vs-AfricanAmerican |
3.773000E-01 |
| Caucasian-vs-Asian |
2.409600E-01 |
| AfricanAmerican-vs-Asian |
9.962000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.6242562850266E-12 |
| Male-vs-Female |
8.955400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.67676983409137E-12 |
| Normal-vs-Age(41-60Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
1.570980E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.045600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.071700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.550200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.424600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.259400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.185800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.64920000053937E-07 |
| Classical-VS-Follicular |
6.289700E-02 |
| Classical-VS-Other |
4.065800E-01 |
| Classical-VS-Normal |
1.29607435894741E-12 |
| Tall-VS-Follicular |
9.999300E-03 |
| Tall-VS-Other |
1.230370E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
9.795400E-01 |
| Follicular-VS-Normal |
1.70341518668238E-12 |
| Other-VS-Normal |
2.003400E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.98474570112239E-12 |
| N0-vs-N1 |
9.335000E-01 |
|
|
